Frazier Life Sciences Acquisition Corp. II
NNASDAQ:FLSC10.27
USD
-0.03
(-0.29%)
CIK
2153598
ISIN
KYG371031017
CUSIP
G37103101
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Albert Cha
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- 1001 Page Mill Road, Building 4, Suite 200B Palo Alto CA United States 94304
- IPO Date
- Oct 14, 2026
- CIK
- 0002153598
- Similar Companies
- Business
- Frazier Life Sciences Acquisition Corp. II operates as a blank check company. It is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 7, 2026 and is headquartered in Palo Alto, CA.
Company News
Insider Buying: Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) CEO Purchases $3,000,000.00 in Stock
U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings